Aims Psychological comorbidity, such as depression and/or diabetes-specific emotional distress (diabetes distress), is widespread in people with Type 2 diabetes and is associated with poorer treatment outcomes. Although extensive research into the prevalence of depression has been conducted, the same attention has not been given to diabetes distress. The aim of this systematic review was to determine the overall prevalence of diabetes distress in people with Type 2 diabetes.
Introduction
Psychological comorbidity is high in people with Type 2 diabetes with extensive research demonstrating that~30% of patients experience depressive affect [1] [2] [3] . More recently linked to Type 2 diabetes is diabetes-specific emotional distress (diabetes distress), which encapsulates a much wider affective experience than depression, constituting distinctive emotional concerns within the 'spectrum of patient experience' for those living with a progressive and chronic condition [4] [5] [6] [7] . Diabetes distress refers to psychological distress specific to living with diabetes and can encompass a wide range of emotions, such as feeling overwhelmed by the demands of self-management required through adherence to diet, exercise and medication prescriptions. People with Type 2 diabetes may worry and ruminate about existing or future complications, hold concerns about existing comorbidities, be fearful of hypoglycaemia and harbour feelings of guilt or shame, notably in relation to obesity or lifestyle [8, 9] .
Both depression and diabetes distress have been shown to impact negatively in Type 2 diabetes through poor adherence and reduced self-care [10] [11] [12] . Although depression and diabetes distress are correlated conditions, research has drawn a distinction between the two conditions suggesting that diabetes distress is more widespread than depression [13] . In addition, the literature suggests that diabetes distress has a greater impact upon, and is more closely associated with, diabetes self-management and diabetes-related Correspondence to: Nicola E. Perrin. E-mail: n.e.perrin@gmail.com behavioural and biomedical outcomes than depression. Most notably, there appears to be an effect of diabetes distress on HbA 1c , whereas the impact of depression appears to be equivocal [9, [14] [15] [16] [17] [18] . A study by Fisher et al. [19] looking specifically at the relationships between depression, diabetes distress and HbA 1c demonstrated that only diabetes distress, and not major depressive disorder or depressive symptoms, held cross-sectional and time-varying longitudinal relationships to HbA 1c , highlighting the importance of exploring the concept of diabetes distress in this patient population.
A large proportion of research combines Type 1 and Type 2 diabetes populations when exploring diabetes distress, however, this can be problematic because the way in which diabetes distress manifests in the two populations may be contextually different; such as fear of hypoglycaemia being a more prominent fear in patients with Type 1 diabetes, or feelings of guilt/shame being more prominent in patients with Type 2 diabetes. The two validated scales used to assess diabetes distress are the Problem Areas in Diabetes (PAID) scale [20] and the Diabetes Distress Scale (DDS) [21] . The PAID can be used for both Type 1 and Type 2 diabetes, whereas the DDS offers a more comprehensive assessment, to overcome psychometric limitations of the PAID, and is specifically for people with Type 2 diabetes. It has previously been emphasized that the information collected from patients with Type 1 diabetes using the PAID scale would likely differ from that found in people with Type 2 diabetes or a mixed Type 1/Type 2 diabetes population [22] , with leading authors recently developing a separate DDS scale for people with Type 1 diabetes, the T1-DDS [23] .
To date, there has been no systematic review and metaanalysis looking specifically at the prevalence of diabetes distress in people with Type 2 diabetes only. The current review sought to address this gap in the literature and provide novel data on the prevalence of diabetes distress in people with Type 2 diabetes, acknowledging the need to assess this separately from individuals with Type 1 diabetes to be able to give greater clarity of understanding and extrapolation of findings to further research and clinical practice.
Methods

Search strategy and selection
Bibliographic databases were searched using a combination of free-text and medical subject heading (MeSH)/Thesaurus terms, including EMBASE (1974 to 2016 week 44), MED-LINE (1946 to 2016 week 44), PSYCINFO (1954 PSYCINFO ( to 2016 , CINAHL (1993 to 2016), The Cochrane Library, the Applied Social Sciences Index and Abstracts (ASSIA) (all dates) and SCOPUS (all years to present). The search strategy was circulated to members of the project team (KK, FS, NR, MD) to advise on any further potential terms and these were added to the search. The finalized search (Fig. S1 ) for this review was conducted on 5 November 2016.
The inclusion and exclusion criteria for this review were developed alongside the review question using the PICOS (participants, interventions, comparisons, outcomes, and study design) approach [24] . The criteria were deliberately broad, focusing only on 'participants' and 'outcome', to capture as many studies as possible within the diabetes distress literature since this is a relatively new field of study and data were limited. Studies were selected, regardless of methods, if they reported a baseline outcome measure of diabetes distress within an adult population (≥ 18 years) with Type 2 diabetes. For studies in which both Type 1 and Type 2 diabetes populations were present, studies with a majority of Type 2 diabetes (≥ 70%) were included. To ensure external validity, experimental studies were included if samples were from varied populations and platforms and adopted broad inclusion criteria (Type 2 diabetes and adult age). Studies were excluded if they were not reported in the English language.
Two reviewers (NP, SB) independently assessed abstracts and titles for eligibility and retrieved potentially relevant articles using a shared paper-selection form developed specifically for purpose to facilitate mutual understanding (Fig. S2) . The reviewers then met to discuss any differences in opinion, which were resolved through discussion; there were few instances where this occurred (< 5%) and no requirement for a third reviewer.
Data extraction
The main outcome measure to be extracted was a measure of diabetes distress, taken as the number and percentage of the overall population scoring over the threshold for significant distress, dependent on the measure used. For studies reporting the PAID scale as their outcome measure, the cut-off point was set at 40 as this is deemed high and has discriminative validity [25, 26] . For studies reporting the PAID-5, a short-form version of the PAID, the cut-off was ≥ 8 [27] . For studies using the DDS, where the total is taken as an average, rather than cumulatively, with moderate distress considered as 2.0-2.9, the cut-off was ≥ 2 for the purposes of this review [28] . Further data extracted included: study design, outcome measure used, study location and year, sample size, distribution, population demographics, biomedical outcomes such as HbA 1c and BMI, and comorbid depression scores. Data was extracted by one reviewer (NP) using a standardized form in Microsoft Excelâ (version 14.2.3) (Fig. S3) . Where the primary outcome (diabetes distress) data were missing, incomplete or unclear, study authors were contacted for additional data and/or clarification. If authors were unreachable due to out of date contact information or did not respond then studies were excluded from the final analyses.
Study quality
Study quality was assessed using previously established guidelines for the critical appraisal and scoring of health research literature for the prevalence or incidence of a health problem and adapting these specifically to the prevalence of diabetes distress [29] (Table S1 ). The guidelines propose three broad areas of exploration to determine the validity of the study methods, the interpretation of the results and the applicability of the results. Each study was appraised to examine the appropriateness of design and sampling, whether the sample size was adequate (n ≥ 300), whether the measures were standardized and recorded without bias, if adequate response rates were seen (≥ 70%), if prevalence scores were reported with confidence intervals, and whether the study subjects and setting were representative of the current research question. A maximum score of eight was available with study strength margins defined as 'poor' (scores of 1 or 2), 'moderate-poor' (scores of 2 or 4), 'moderate-strong' (scores of 5 or 6) and 'strong' (scores of 7 or 8).
Meta-analyses
The primary outcome was the total number of participants and number of participants demonstrating significant levels of diabetes distress, which we analysed using 'metaprop', a statistical program implemented to perform meta-analyses of proportions [30] in STATA (version 14.1). Metaprop delivers both fixed and random effects pooled estimates and we used the Freeman-Tukey double arcsine transformation to stabilize the variances [31] . Heterogeneity was assessed using an I 2 statistic to establish whether variations between studies included in the meta-analyses were due to chance. The value is expressed as a percentage of the total variation across studies that is attributed to heterogeneity rather than chance, which was quantified as low (25%), moderate (50%) and high (75%) using tentative cut-off points suggested by previous authors [32] . Publication bias was assessed using Egger's test [33] and a funnel plot. Secondary random-effects meta-analyses were conducted to determine and compare the prevalence of diabetes distress and to identify potential sources of heterogeneity using metaregression analyses across the following variables: diabetes distress scale used (DDS, PAID and PAID-5); study location (region); population culture (eastern, western); mean age of participants (30-39, 40-49, 50-59, 60-69, 70-79 years); gender majority (≥ 50% female, ≥ 50% male); ethnicity majority (≥ 50% white, ≥ 50% non-white); mean BMI (≤ 30, ≥ 30); mean HbA 1c [53.0-62.8 mmol/mol (7.0-7.9%), 63.9-73.8 mmol/mol (8.0-8.9%), 74.9-84.7 mmol/ mol (9.0-9.9%), 107.7-117.5 mmol/mol (12.0-12.9%)]; mean years since diagnosis of Type 2 diabetes (2.0-3.9, 4.0-5.9, 6.0-7.9, 8.0-9.9, 10.0-11.9, 12.0-13.9, 14.0-15.9); percentage of diabetes-related complications and/or comorbidities (10-19, 20-29, 30-39, 40-49, 50-59 , 60-69, 70-79, 80-89, 90-99); and comorbid depressive symptoms (0-9%, 10-19%, 20-29%, 30-39%, 40-49%, 50-59%, 60-69%). All available data were extracted and meta-regression variables were determined a posteriori once sufficient available data were determined.
Owing to varied reporting of complications and/or comorbidities across studies, careful consideration was given to data inclusion within the analysis. Twenty-nine studies reported data for complications and/or comorbidities, with terms used interchangeably across studies. The current reporting of 'comorbidities and/or complications' is defined as physical conditions only. Studies that did not state whether their data pertained to physical or psychological conditions were excluded from the analysis. Where possible, meta-regression analyses were performed for individual comorbid conditions, with sufficient data available for hypertension, dyslipidaemia, retinopathy, heart disease, neuropathy, nephropathy and foot ulcers. Study location regions were grouped into the six regions articulated by the World Health Organization [34] : Americas, Eastern Mediterranean, Western Pacific, Southeast Asia, European, Africa. Regarding culture, populations were split into either Eastern or Western cultures; Western cultures were defined as those developing from Europe and their historic expansion into the Americas and Australasia.
Results Figure 1 demonstrates the study selection process. Searches generated 6048 citations, of which 3105 titles and abstracts were screened for eligibility once duplicates were removed. Of these, 283 potentially relevant studies were selected for full text retrieval, of which 159 were eligible for the review, and 55 were eligible and provided sufficient data to be included within the meta-analyses (Refs e1-e54, Doc. S1). One paper (Ref. e8, Doc. S1) reported data for two separate studies and these were separated for the analyses.
Studies included in the meta-analyses are summarized in Table 1 . Diabetes distress was measured using either the PAID (n = 25), the PAID-5 short-form version (n = 9) or the DDS (n = 21).
Studies were conducted within the last 16 years, with data collected from the USA (n = 20), Canada (n = 7), the Netherlands (n = 5), Australia (n = 6), China (n = 3), Singapore (n = 2), France (n = 1), Germany (n = 1), Italy (n = 1), India (n = 1), Iran (n = 1), Japan (n = 1), Malaysia (n = 1), Norway (n = 1) Serbia (n = 1), Slovenia (n = 1) and South Africa (n = 1); there was one multinational study.
Most studies in this review adopted an observational design (n = 43), with 12 experimental studies. Samples sizes within the studies ranged from 21 to 8596. The average age of participants in the studies was 57.4 years (range: 32.3-70.0 years), with an even split of gender (51% men). The minority of people (38%) were of white ethnicity.
Participants had been diagnosed with Type 2 diabetes for an average of 9.7 years (range: 2.9-15.6 years) and had an average HbA 1c of 67.2 mmol/mol (8.3%) (range: 53.0 to 107.7 mmol/mol; 7.0-12.0%). The average BMI in participants was 31.7 kg/m 2 (range 26.5-36.8 kg/m 2 ).
Study quality assessment (Table S1 ) demonstrated a mean score of 5.2 of 8, with the majority of studies (n = 36, 64.2%) scoring 'moderate-strong'. The remaining studies consisted of three scoring as 'poor' (5.4%), nine scoring as 'poor-moderate' (16.1%) and eight scoring as 'strong' (14.3%).
Fifty-five studies, with a total of 36 998 participants, reported the number/percentage of participants demonstrating significant diabetes distress and were included in fixedand random-effects meta-analyses to determine the overall prevalence of diabetes distress in people with Type 2 diabetes (Fig. 2) .
The overall prevalence of diabetes distress was 36%; random-pooled effect size (ES) 0.360 [95% confidence interval (95% CI) 0.308, 0.413], fixed-pooled ES 0.356 (95% CI 0.351, 0.361). Heterogeneity was shown to be very high with I 2 = 99.03, with meta-regression analyses identifying potential confounders in gender distribution (P = 0.011) and comorbid depressive symptoms (P = 0.009); finding prevalence to be increased in studies with a female sample majority and in samples with comorbid depressive symptoms ( Table 2 ). Eggers test (P = 0.119) suggested that publication bias was absent. The funnel plot, however, demonstrated asymmetry, with a greater representation of studies where higher diabetes distress proportions were seen, indicating potential for bias (Fig. S4) .
Discussion
Key findings
This comprehensive meta-analysis of 55 studies showed that the overall prevalence of diabetes distress using established cut-off scores in people with Type 2 diabetes was 36%, with secondary analyses identifying gender (P = 0.010) and comorbid depressive symptoms (P = 0.008) as significant factors affecting prevalence.
Strengths and limitations
This is the first known systematic review and meta-analyses of the existing literature to determine the prevalence of diabetes distress in a solely Type 2 diabetes population. As such, it provides novel information for a gap in the literature. The methods used to carry out this review were robust, adopting strategies to gain all relevant outcome data available, even when not reported. Although it is a potential strength that this review is the first of its kind, it meant that the data available were limited, because the field of diabetes distress is a relatively new one. This was further hindered by the vast majority of papers not reporting the data required for the analyses, and despite extensive efforts to contact authors for any missing data or to clarify any discrepancies, this often proved unsuccessful, either due to contact details no longer being valid and/or receiving no reply.
There was high heterogeneity between studies, with particular concern lying in the reporting of diabetes distress and the scales used. A number of studies that reported DDS scores conveyed the score as a cumulative rather than an average, meaning that their results were dramatically higher than the majority of studies. As such, if authors did not respond to requests for an average score, these studies needed to be excluded so as not to bias the results. Similarly, the reporting of comorbid depressive symptoms/depression was highly varied with 10 different scales reported, two studies reporting diagnoses by clinical diagnostic interview and one study merely stating the percentage that has 'regular MD' (major depression). Although further heterogeneity between studies was evident in terms of study location and population demographics, this was useful in terms of understanding the prevalence of diabetes distress across variables.
Overall study quality demonstrated a moderate risk of bias, with the majority of studies scoring as 'moderatestrong'. We observed a large proportion of negative counts resulting from a lack of reporting, such as insufficient reporting of response rates or details of assessors. Further points were lost due to 43.6% of studies having inadequate sample sizes. The most prominent loss of points came from prevalence rates not being reported with confidence intervals, with the vast majority of studies either reporting diabetes distress as n (%) or mean (SD). Nearly all studies clearly specified and defined their eligibility criteria and recruited from either a randomized or a whole population sample of the same/similar populations. Having appraised each study, we feel that for the purposes of the current findings, the samples were representative of the target population and while heterogeneity was high, this offered useful exploration within our analyses.
Analyses to determine if publication bias was evident offered inconsistent results. While the funnel plot shows asymmetry, Egger's test deemed that publication bias was not present. It is possible that the distribution within the funnel plot, namely an excess of studies to the right of the plot, could suggest a bias in that studies with higher results of diabetes distress are more likely to be published.
Surrounding evidence and implications
Elevated levels of diabetes distress appear to be widespread with estimates given by leading authors varying between 18% and 35% [7, 28] in combined Type 1 diabetes and Type 2 diabetes populations, with a recent systematic review and meta-analysis looking into the prevalence of diabetes distress in research populations demonstrating a prevalence of 22% [35] . A study by Fisher et al. in 2008 explored the longitudinal rates of affective disorders, including diabetes distress, demonstrating an approximate point prevalence of 46% in people with Type 2 diabetes [16] . The current findings demonstrated a 36% prevalence of diabetes distress in people with Type 2 diabetes, which is higher than the research combining Type 1 diabetes and Type 2 diabetes populations and could be indicative of a difference between how diabetes distress manifests and presents in these populations. Although research has shown that rates are similar when appropriate type-specific scales are used, with a 42.1% point prevalence and 54.4% incidence of diabetes distress in people with Type 1 diabetes, and 46.2% and 54.3% in people with Type 2 diabetes respectively [23] . The current The results demonstrated that diabetes distress was significantly higher in samples with a majority of women compared with samples with a majority of men. Previous studies have recognized a link between female gender and diabetes distress, as well as depression and anxiety, with greater risk in women compared with men [13, 16] . This increased presence of expressed emotional difficulties in women with Type 2 diabetes may be attributable to differing social conventions regarding gender: men appear less likely to seek help and/or admit distress due to a need to appear capable or for fear of being emasculated by showing weakness [36] . A further argument could be that men may try to fulfil 'masculine' gender identities, such as problem solving, which could encourage them to privilege treatment advice to overcome their condition [37] . Although such stereotypes may be less prevalent in younger cohorts, amongst older generations, who are over-represented in the studies reviewed, these gender identities may pertain and partially explain why emotional difficulties appear less common in men. This reiterates a need to take account of an individual's personal presentation and circumstance when approaching assessment of well-being both psychologically and in terms of physiological diabetes-related issues, to ensure the best identification of issues to treat and offer appropriate management of these.
Our findings also demonstrated a significant difference in diabetes distress rates when accounting for the prevalence of comorbid depression in the samples, with significantly lower prevalence of diabetes distress in samples with low to no prevalence of comorbid depression. This supports existing research highlighting that diabetes distress and depression are highly correlated constructs [38] [39] [40] [41] [42] [43] . Research has emphasized concerns with poor recognition in both depression [44] [45] [46] [47] [48] and diabetes distress [43, 49] , with a substantial overlap between symptoms and presentation of both conditions. It is important to consider when assessing psychological status in people with Type 2 diabetes that these are different constructs that can either coexist, occur in isolation, or present distinct from one another.
Prevalence of diabetes distress appeared higher in studies reporting the DDS compared with the PAID and the PAID-5 scales, although this difference was non-significant. It would be advantageous for future research to explore this further to see whether the increased prevalence scores seen with the DDS vs. the PAID scale might be due to varying stringency in their opposing criteria (40% vs. 20% thresholds), with our findings corroborated by higher reported diabetes distress in the USA, where the DDS is more predominantly used, compared with Europe [26] . A recent study comparing the DDS and PAID acknowledged that although both scales are excellent psychometric self-report measures, they bear fundamental differences in terms of the domains they address [50] . For example, the authors noted that the PAID scale encapsulates a broader range of emotional concerns than the DDS, the latter encompassing factors more closely linked to diabetes self-management. This could explain the differences in prevalence between the measures found in the present findings, because the scales themselves explore fundamentally different aspects of diabetes distress. This also elucidates concerns about the disparity in defining and assessing diabetes distress; because there is no one-single definition or diagnostic criterion for diabetes distress, this leaves open further obstacles in properly identifying, and thus treating, people with Type 2 diabetes who present with comorbid psychological difficulties. This issue is further clouded when considering the grouping of Type 1 diabetes and Type 2 diabetes together when exploring the notion of diabetes distress. Although there is evidence to suggest that there are no fundamental differences in reported diabetes-related stressors between the two condition types using the PAID scale [26] , using specific scales developed for Type 1 and Type 2 diabetes, such as the T1-DDS and T2-DDS, may foster better understanding of the experience and care needs of these individuals.
Conclusion
The findings of this review demonstrate that diabetes distress is a prominent issue in people with Type 2 diabetes, and that it is greater in groups with a female gender majority and with higher prevalence of comorbid depressive symptoms. Depression and diabetes distress are highly related and both appear to be under-recognized and inadequately treated in Type 2 diabetes. The findings of this review highlight the importance of the identification and subsequent management of diabetes distress and/or depression in people with Type 2 diabetes, with particular priority given to the use of appropriate scales and the interpretation of findings to allow for patient-centred and suitably tailored care. Further work is required to explore psychological comorbidity in people with Type 2 diabetes and gain better understanding of how best to support them.
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